{"title":"Management of type 2 diabetes: the GLP-1 pathway","authors":"Abd A Tahrani MMedSci, MD, MRCP, Milan K Piya MRCP, Anthony H Barnett MD, FRCP","doi":"10.1002/fps.39","DOIUrl":null,"url":null,"abstract":"<p>Type 2 diabetes mellitus (T2DM) is a major challenge to healthcare systems around the world, with an estimated prevalence of 6% (246 million) in 2007 rising to 7.3% (380 million) in 2025 worldwide.1–5 In this article, the authors consider the significance of the GLP-1 path-way in the management of T2DM, and some of the advantages of incretin-based therapy. Copyright © 2008 John Wiley & Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"9 3","pages":"18-24"},"PeriodicalIF":0.0000,"publicationDate":"2009-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.39","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.39","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Type 2 diabetes mellitus (T2DM) is a major challenge to healthcare systems around the world, with an estimated prevalence of 6% (246 million) in 2007 rising to 7.3% (380 million) in 2025 worldwide.1–5 In this article, the authors consider the significance of the GLP-1 path-way in the management of T2DM, and some of the advantages of incretin-based therapy. Copyright © 2008 John Wiley & Sons, Ltd.
2型糖尿病的治疗:GLP-1通路
2型糖尿病(T2DM)是全球卫生保健系统面临的主要挑战，据估计，2007年全球患病率为6%(2.46亿)，到2025年将上升至7.3%(3.8亿)。在这篇文章中，作者考虑了GLP-1通路在T2DM管理中的重要性，以及基于肠促胰岛素治疗的一些优势。版权所有©2008 John Wiley &儿子,有限公司
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
